Pear Therapeutics, Inc. – NASDAQ:PEARW

Financial Health
0
1
2
3
4
5
6
7
8
9

Pear Therapeutics stock price monthly change

-93.76%
month

Pear Therapeutics key metrics

Market Cap
4.08M
Enterprise value
2.54B
P/E
-27.52
EV/Sales
135.88
EV/EBITDA
-18.45
Price/Sales
137.91
Price/Book
84.50
PEG ratio
124508.59
EPS
0.16
Revenue
12.69M
EBITDA
-169.39M
Income
24.77M
Revenue Q/Q
-39.04%
Revenue Y/Y
201.66%
Profit margin
-501%
Oper. margin
-1018.74%
Gross margin
35.62%
EBIT margin
-1018.74%
EBITDA margin
-1334.48%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Pear Therapeutics stock price history

Pear Therapeutics stock forecast

Pear Therapeutics financial statements

Pear Therapeutics, Inc. (NASDAQ:PEARW): Profit margin
Mar 2022 2.74M -12.97M -472.06%
Jun 2022 3.29M 43.74M 1326.78%
Sep 2022 4.08M -34.81M -852.73%
Dec 2022 2.56M 28.82M 1123.86%
Pear Therapeutics, Inc. (NASDAQ:PEARW): Debt to assets
Mar 2022 172092000 102.58M 59.61%
Jun 2022 142519000 63.47M 44.54%
Sep 2022 119735000 67.48M 56.37%
Dec 2022 95129000 64.54M 67.85%
Pear Therapeutics, Inc. (NASDAQ:PEARW): Cash Flow
Mar 2022 -36.70M -43.5M 75K
Jun 2022 -29.63M -307K 761K
Sep 2022 -23.27M 22.42M 358K
Dec 2022 -24.28M 11.93M 961K

Pear Therapeutics alternative data

Pear Therapeutics, Inc. (NASDAQ:PEARW): Employee count
Aug 2023 200
Sep 2023 200
Oct 2023 200
Nov 2023 200
Dec 2023 200
Jan 2024 200
Feb 2024 200
Mar 2024 200
Apr 2024 200
May 2024 200
Jun 2024 200
Jul 2024 200

Pear Therapeutics other data

  • When is Pear Therapeutics's next earnings date?

    Unfortunately, Pear Therapeutics's (PEARW) next earnings date is currently unknown.

  • Does Pear Therapeutics pay dividends?

    No, Pear Therapeutics does not pay dividends.

  • How much money does Pear Therapeutics make?

    Pear Therapeutics has a market capitalization of 4.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 201.66% to 12.69M US dollars.

  • What is Pear Therapeutics's stock symbol?

    Pear Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "PEARW".

  • What is Pear Therapeutics's primary industry?

    Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.

  • How do i buy shares of Pear Therapeutics?

    Shares of Pear Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Pear Therapeutics have?

    As Jul 2024, Pear Therapeutics employs 200 workers.

  • What is Pear Therapeutics's official website?

    The official website for Pear Therapeutics is peartherapeutics.com.

  • Where are Pear Therapeutics's headquarters?

    Pear Therapeutics is headquartered at 200 State Street, Boston, MA.

  • How can i contact Pear Therapeutics?

    Pear Therapeutics's mailing address is 200 State Street, Boston, MA and company can be reached via phone at 833 697 3738.

Pear Therapeutics company profile:

Pear Therapeutics, Inc.

peartherapeutics.com
Exchange:

NASDAQ

Full time employees:

200

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

200 State Street
Boston, MA 02109

CIK: 0001835567
:
CUSIP: 704723113